Millennium Management
TELO icon

Millennium Management’s Telomir Pharmaceuticals TELO Stock Holding History

Millennium Management’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$168K Sell
129,060
-37,915
-23% -$48.4K ﹤0.01% 5231
2025
Q4 		$222K Sell
166,975
-55,429
-25% -$80K ﹤0.01% 5422
2025
Q3 		$309K Sell
222,404
-25,295
-10% -$38.1K ﹤0.01% 5326
2025
Q2 		$310K Buy
+247,699
New +$573K ﹤0.01% 5177

Other funds holding TELO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Millennium Management's TELO Position: Q1 2026 in Review

Millennium Management reduced its Telomir Pharmaceuticals (TELO) stake by 23% in Q1 2026, selling an estimated $48.4K and leaving 129,060 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #5231.

Millennium Management first reported a position in TELO in Q2 2025 and has held it in 4 quarters since. The position peaked at $310K in Q2 2025. 27 funds tracked by Wall St. Rank hold TELO as of Q1 2026.

  • Millennium Management held 129,060 shares of Telomir Pharmaceuticals worth $168K as of Q1 2026.
  • Millennium Management sold 37,915 Telomir Pharmaceuticals shares in Q1 2026, an estimated $48.4K.
  • Telomir Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5231 holding.
  • Millennium Management first reported a position in Telomir Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Millennium Management's Telomir Pharmaceuticals position peaked at $310K in Q2 2025.
  • 27 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.